Narrow Results

Australia Announces Funding for Cutting Edge Biotechnology.

Australian Plant Research Facility Enables World Class Research.

China-UN Joint Project to Improve Agriculture Product Processing.

World Bank Lends China US$104 Million for Anti-TB Program.

Taking Singapore Ahead in the Realm of Neuroscience.

Stem Cell Expert Moves to Singapore.

Singapore to Set up New Bioengineering Institute.

Thailand Bids for More Rice Export Quota to China.

Singapore Law Gets Ready to Meet Novelties of Life Sciences Industry.

CSIRO Life Sciences Center Opens.

Australia to Buy Smallpox Vaccine.

China and ASEAN to Collaborate on Functional Food.

China Faces Impending Cardiovascular Epidemic.

No Dengue Tests for Blood Supply.

Panel to Promote Biotechnology in India.

Japan to Boost Annual Biotech Expenditure.

Japanese Workers Suffer from Depression.

NZ to Join Trend for Designer Babies.

NZ and Novartis in Provisional Glivec Deal.

Software to Help in Ethical Dilemmas.

Philippines Authority Assures Safety of Biotech Food.

Survey Shows Asians More Receptive towards GM Foods.

Taiwan Plans to Promote Biotech.

India and Japan's Life Sciences Industries Hold Great Promise.

Bioinformatics techniques to protein secondary structure prediction, such as Support Vector Machine (SVM) and GOR approaches, are mostly single-stage approaches; they predict secondary structures of the protein by taking into account only the information available in amino acid sequences. On the other hand, PHD (Profile network from HeiDelberg) method is a two-stage technique where two Multi-Layer Perceptrons (MLPs) are cascaded; the second neural network receives the output of the first neural network captures any contextual relationships among the secondary structure elements predicted by the first neural network. In this paper, we argue that it is feasible to extend the current single-stage approaches by adding a second-stage prediction scheme to capture the contextual information among secondary structural elements and thereby improving their accuracies. We demonstrate that two-stage SVMs perform better than present techniques for protein secondary structure prediction.

Opening of DNA Learning Lab at the Singapore Science Center.

Overview of Singapore’s Life Sciences Education Plan.

This article is a perspective from an educational institute. It states how Singapore is shaping its educational focus on the boom in biomedical sciences.

An Exclusive Interview with Executive Vice Dean of Duke—NUS Graduate Medical School Singapore, Dr Ranga Krishnan.

Developing the Family Physicians in Singapore.

Interview with Director of MDIS school of Life Sciences: Dr Andrew P. Lucy.

An Interview with Dr Jong Wook Lee — Chairman of Daewoong Pharmaceuticals.

An Exclusive on LG Life Sciences.

An Insight into Phylogica — An Australian Biopharmaceutical Company.

Cytopia — One of Australia's Most Successful Biotech Companies.

Mesoblast Limited Key Bone Repair Patent Granted In The United States.

Lilly to Acquire Global License to AXIRON Testosterone Solution from Acrux Tools.

China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank.

AutekBio to Build Largest Biologic CMO in Asia.

3SBio, Ascentage Pharma to Jointly Develop Cancer Therapeutics.

SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS.

Ceragenix Enters into Agreement with Korea's BexPharm.

SRL Launches Sports Gene Test for the First Time in India.

Fortis Acquires Stake in Singapore's Parkway Holdings.

Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt.

AMPAC Fine Chemicals Partners With Inabata & Co., Ltd. of Japan.

Astellas Entered into Global Partnership with Basilea for an Azole Antifungal Agent Isavuconazole.

Medicago, NITT to Develop Vaccine in Japan.

Millipore Launches New Water Purification System for Ion Chromatography.

Why Invest in Life Sciences and Healthcare?

Brisk Business Accomplishments Observed at AnaLabAsia2011, Controls, Instrumentation and Automation 2011 and EnviroAsia 2011.

BioAsia to take a New Avatar in 2012 as a Lifesciences Advocacy and Global Networking Platform.

Using Bioinformatics to Understand the Antibody Response.

Genomic Translational Research: From Bench to Bedside.

Understanding DNA-Protein Interactions for Applications in Genome Engineering.

Overview of Bioinformatics Research in Japan.

Perdana University Centre for Bioinformatics: Contributing to the Growth of Bioinformatics in Malaysia.

Bioinformatics for Vaccine Target Discovery.

The Bioinformatics Institute, A*STAR – Innovation in Bits and Bytes.

The Increasing Need for Bioinformatics in Life Science and Biotechnology Research.

APACMed in MedTech Industry – Insights from Brent Scott

L’Oréal Supports Women Contributing in Science Industry

China boosts plans to motivate its scientists.

Chinese researcher recognized by World Food Prize.

Breakthrough new rice variety announced in Northern China.

Ebola vaccine approved in China.

Study reveals anti-cancer properties of a fungus used in traditional medicine.

CRISPR bacon: Chinese scientists create genetically modified low-fat pigs.

A new weapon of fighting Malaria.

Gene sequencing technology saw rapid growth in China.

Chinese scientists map genome sequences for Peony.

Werum IT Solutions and Neotrident sign partnership in China.

The story of WeDoctor

The past, present and future of life science

While open innovation is a management concept of increased attention in academia as well as in industry, studies have also shown that the implementation of open innovation can be a rather difficult and challenging process. Installed organisational structures, culture and knowledge are often portrayed as hinder for change. This study provides an in-depth case study, based on 50 interviews, of how a large pharmaceutical corporation implemented an open innovation initiative. Instead of considering existing internal knowledge and structures as problematic, these resources were rather utilised as cornerstones for value offerings in open innovation. Furthermore, employees’ engagement in open innovation resulted in a more open and dynamic climate, as well as an improved entrepreneurial image of the corporation internally as well as externally. The study contributes to the open innovation literature by advancing the understanding about the organisational implications of implementing open innovation in practice. As such, it provides valuable insights for researchers and practitioners about implementing open innovation in practice.

Although the concept of open innovation has gained much attention in the field of innovation management, few studies have so far theorized how such initiatives are being enacted in practice. This study is based on an inductive empirical analysis of how AstraZeneca, a large biopharmaceutical corporation, implemented an open innovation initiative called BioVentureHub. In the paper we introduce a theoretical model of open innovation enactment based on four interrelated processes. Three of these processes — conceptualization, mobilization, and operationalization — include activities related to preparing for open innovation, what we call open innovation groundwork. The fourth process — facilitation — involves translating the groundwork into actual open innovation.

The study contributes to the broader open innovation domain by its detailed account and theorizing of how open innovation is established in practice. Our methodological approach complements the previous research on open innovation that mostly are based on retrospective accounts or are conceptual in nature. Moreover, the study contributes by illustrating a novel initiative from the life science industry, where open innovation is frequently discussed but where still only a few empirical examples are found in academic literature